Nashville, Tennessee — Nashville, Tennessee

Nashville, Tennessee is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Nashville, Tennessee has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Seizures, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Sponsors: AbbVie, EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville, Tennessee?

Nashville, Tennessee has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville, Tennessee conducted?

Nashville, Tennessee has 4 clinical trials on record, with 2 currently active. Their work covers Seizures, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Is Nashville, Tennessee accredited by Crixeo Health?

Nashville, Tennessee has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville, Tennessee?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.